U.S. Markets closed

How CEO Stonehouse is building up BioCryst's war chest to finance trials, drug launch

Seth Thomas Gulledge
How CEO Stonehouse is building up BioCryst's war chest to finance trials, drug launch

On Nov. 6, detailing the company's third quarter earnings to a handful of analysts, BioCryst Pharmaceuticals' longtime CEO, Jon Stonehouse, said he sees 2019 to be a transformative year for the company.